Related Experiment Video
Updated: Jun 18, 2026
05:48
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Shared decision making models to inform an interprofessional perspective on decision making: a theory analysis.
Dawn Stacey1, France Légaré, Sophie Pouliot
1Faculty of Health Sciences, School of Nursing, University of Ottawa, Ottawa, Ontario, Canada. dstacey@uottawa.ca
Patient Education and Counseling
|December 1, 2009
Summary
Most shared decision-making (SDM) models lack interprofessional collaboration elements. Current models inadequately address team-based care, indicating a need for more inclusive conceptualizations in clinical practice.
Area of Science:
- Health Services Research
- Clinical Practice Models
- Decision Science
Background:
- Shared decision-making (SDM) is crucial for patient-centered care.
- Interprofessional collaboration enhances healthcare outcomes.
- Existing SDM models require evaluation for their applicability in team-based settings.
Purpose of the Study:
- To analyze shared decision-making (SDM) conceptual models.
- To assess the relevance of SDM models to interprofessional collaboration in clinical settings.
Main Methods:
- Theory analysis of SDM models from systematic reviews and personal files.
- Inclusion criteria focused on SDM models with described concepts and relational statements.
- Independent appraisal of selected models.
Main Results:
- 15 unique SDM models were identified from 54 publications, comprising 18 core concepts.
- Only two models incorporated multiple healthcare professionals; one included 3/10 interprofessional collaboration elements, the other 1/10.
- Models were generally rated high for logical adequacy and parsimony, but only half were empirically tested.
Conclusions:
- Most current SDM models do not adequately integrate interprofessional collaboration.
- Models including multiple professionals demonstrate limited adherence to interprofessional collaboration elements.
- There is a clear need for developing SDM models that are more inclusive of interprofessional teamwork.
Related Concept Videos
01:25Models of Health Promotion and Illness Prevention I
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
01:20Decision Making
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
Automatic decision-making is fast, intuitive, and relies on gut feelings...
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:09Decision Making: P-value Method
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:14Decision Making: Traditional Method
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).